Oncorus's Board Approved The Dissolution And Liquidation Of The Company; It Previously Announced Workforce Reduction Plan Impacting Substantially All Of The Company's Remaining Employees, Which Is Expected To Be Complete By August 2023
Portfolio Pulse from Benzinga Newsdesk
Oncorus's board has approved the dissolution and liquidation of the company, with a workforce reduction plan impacting substantially all remaining employees, expected to be complete by August 2023. Nasdaq will suspend trading of ONCR's common stock on June 20, 2023.
June 12, 2023 | 10:34 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oncorus's dissolution and liquidation will lead to the suspension of its common stock trading on Nasdaq, negatively impacting its stock price.
The company's board has approved the dissolution and liquidation, which will result in a workforce reduction plan impacting most employees. This decision will lead to the suspension of ONCR's common stock trading on Nasdaq, causing a negative impact on its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100